News – Page 832 – Endpoints News

Covid-19 roundup: Anthony Fauci, Stephen Hahn testify in Congress; China's Sinopharm speeds into PhIII vaccine trial

5 years ago

Biohaven reports another trial failure for troriluzole; Cyclica raises C$23M for AI driven discovery platform

5 years ago

Is it really over? La Jolla signs acquisition with Tetraphase after outbidding AcelRx, Melinta

5 years ago

Biogeneration Ventures raises $119M for new fund, adding a personal record to series of VC raises

5 years ago

Day one: The disruptor-in-chief at BridgeBio invites Brent Saunders onto the board

5 years ago

Burned by Alzheimer’s failures, a cautious Merck turns to a startup biotech for some preclinical neuro programs

5 years ago

FDA lifts partial hold on cancer drug after Innate resolves manufacturing issue

5 years ago

UK Supreme Court strikes down Regeneron patents, opening door for Kymab

5 years ago

A virtual biotech incubator is launching with the help of Evotec and Samsara, looking for a few good scientists in ...

5 years ago

With its campus expanding as gene therapy booms, Aldevron brings in a top exec from a medtech giant to steer the ...

5 years ago

Better than Eylea, as durable as gene therapy? Perceptive, Xontogeny boost ophthalmic startup's shot for best of all ...

5 years ago

Hahn testifies on Covid-19 response, says FDA on target to hit user fee goals

5 years ago

Boehringer Ingelheim to cash out Hikma stake; Breast cancer biotech sets terms for IPO

5 years ago

Myovant readies NDA #3 as relugolix sails to its 5th positive PhIII — this time in endometriosis

5 years ago

Seven years after licensing BTK inhibitor from Biogen, beleaguered pennystock biotech partner concedes defeat

5 years ago

Lawmakers ask FDA to outline Covid-19 vaccine approval process

5 years ago

Daniel O’Day snatches another I/O company, buying half of a pioneering cancer drug discoverer's biotech

5 years ago

Meet the latest genomic data company — aka WuXi NextCODE without the China operations

5 years ago

Covid-19 roundup: $71M from DoD to Inovio; Pigs provide clues on Oxford vaccine; Google lends supercomputing to ...

5 years ago

What’s it take to raise $700M-plus for a biotech startup? Steve Harr has some thoughts on that

5 years ago

Sanofi wants to earn the rep for being the hare in drug R&D. But that darn tortoise keeps sticking its head out

5 years ago

Sanofi bets $425M cash on a transformation-style next-gen vaccine deal — as the Big Pharma team makes a point

5 years ago

Evoke Pharma finally lands approval for lead and only drug

5 years ago

Looking at a groundbreaking advance, Myovant gets a priority review at FDA; Agenus, G1 forge new China deals

5 years ago

First page Previous page 829 830 831832833 834 835 Next page Last page